Hematopoietic Stem Cells Transplantation Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Global Hematopoietic Stem Cells Transplantation Market size is projected to reach US$ 3579.5 million by 2028, from US$ 2417.2 million in 2021, at a CAGR of 11% during the forecast period 2022-2028.

Hematopoietic stem cell transplantation is a procedure in which pluripotent hematopoietic stem cells collected from peripheral blood, bone marrow, and umbilical cord blood are transplanted into a patient. Hematopoietic stem cell transplantation is the replacement of defective, diseased, or damaged stem cells with healthy stem cells due to chemotherapy or radiation therapy. Over the past 30 years, the hematopoietic stem cell transplantation market has seen rapid and sustained expansion with advances in life-saving technologies. Hematopoietic stem cell transplantation, also known as blood and bone marrow transplantation, treats about 70 different hematological and non-hematologic disorders while restoring the patient’s immune and medullary function. In general, hematopoietic stem cell transplantation is used for the treatment of genetic, tumor, immune, malignant and nonmalignant blood disorders.

Market Segments

By Type

• Stem Cells Storage
• Stem Cells Consumables

By Application

• Leukemia
• Lymphoproliferative Disorders
• Solid Tumors
• Non-Malignant Disorders

Key Players

Key players operating in the Hematopoietic Stem Cell Transplantation (HSCT) Market are Pluristem Therapeutics Inc., CellGenix GmbH, Regen Biopharma Inc., Lonza Group, Kiadis Pharma, Taiga Biotechnologies, Inc., Takeda Pharmaceutical Company Limited, Escape Therapeutics, Inc., Bluebird Bio, Talaris Therapeutics, Inc., Marker Therapeutics Inc., and Stempeutics Research Pvt Ltd.

Scope of the Report

The research study analyzes the global Hematopoietic Stem Cells Transplantation industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Hematopoietic Stem Cells Transplantation Market Report

1. What was the Hematopoietic Stem Cells Transplantation Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Hematopoietic Stem Cells Transplantation Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Hematopoietic Stem Cells Transplantation Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.